Stephen B. Hanauer
Professor, Feinberg School of Medicine · Feinberg School of Medicine
Credentials: · · · ·
History
Present
- Until 1982
- Until 1981
- 1977
University of Illinois at Chicago College of Medicine
Research
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Nature · 2001 · 3,809 citations
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
The Lancet · 2002 · First of 12 authors · Corresponding · 3,474 citations
Infliximab for induction and maintenance therapy for ulcerative colitis
New England Journal of Medicine · 2005 · 3,208 citations
110 papers · 35 as a resident
49 papers
48 papers
39 papers · 1 as a fellow
29 papers · 2 as a fellow
25 papers
24 papers · 3 as a fellow
- DP
23 papers
Grants
- 2003–2008
Multi-Site Trial of Azathioprine Dosing in Crohn Disease
National Institute of Diabetes and Digestive and Kidney Diseases · U01
Contact PI · $743.8K · University of Chicago
- 2003–2007
Multi-Site Trial of Azathioprine Dosing in Crohn Disease
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $762.3K · University of Chicago
- 1997–2001
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $267.7K · University of Chicago
Clinical trials
- 2020–2022
Treating Chronic Pouchitis With a Low FODMAP Diet
Principal investigator · Withdrawn
Northwestern University
- 2015–2018
To Evaluate the Impact of SBI on C. Difficile in Hospitalized UC Patients
Principal investigator · Terminated
Northwestern University
- 2007–2008
Principal investigator · Terminated · Phase 2
Jacobus Pharmaceutical
- 2005–2007
Imuran Dosing in Crohn's Disease Study
Principal investigator · Terminated · Phase 2
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)